SENATE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 2935

The Commonwealth of Massachusetts

_______________

In the One Hundred and Ninety-First General Court
(2019-2020)

_______________

SENATE, October 29, 2020.

The committee on Senate Ways and Means to whom was referred the Senate Bill relative to insurance coverage for PANDAS/PANS (Senate, No. 613), - reports, recommending that the same ought to pass with an amendment substituting a new draft entitled "An Act requiring certain insurance coverage for pediatric autoimmune neuropsychiatric disorders and pediatric acute-onset neuropsychiatric syndrome" (Senate, No. 2935).

For the committee,

Michael J. Rodrigues

        FILED ON: 10/29/2020

SENATE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 2935

The Commonwealth of Massachusetts

_______________

In the One Hundred and Ninety-First General Court
(2019-2020)

_______________

An Act requiring certain insurance coverage for pediatric autoimmune neuropsychiatric disorders and pediatric acute-onset neuropsychiatric syndrome..

Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
 

SECTION 1. Chapter 32A of the General Laws is hereby amended by inserting after section 17Q the following section:-

Section 17R. The commission shall provide to any active or retired employee of the commonwealth who is insured under the group insurance commission coverage for treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome, including, but not limited to, the use of intravenous immunoglobulin therapy.

SECTION 2. Chapter 175 of the General Laws is hereby amended by inserting after section 47LL the following section:-

Section 47MM. Any policy, contract, agreement, plan or certificate of insurance issued, delivered or renewed within the commonwealth shall provide coverage for treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome including, but not limited to, the use of intravenous immunoglobulin therapy.

SECTION 3. Chapter 176A of the General Laws is hereby amended by inserting after section 8NN the following section:-

Section 8OO. Any contract between a subscriber and a corporation under an individual or group hospital service plan delivered, issued or renewed within the commonwealth shall provide coverage for treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome including, but not limited to, the use of intravenous immunoglobulin therapy.

SECTION 4. Chapter 176B of the General Laws is hereby amended by inserting after section 4NN the following section:-

Section 4OO. Any subscription certificate under an individual or group medical service agreement delivered, issued or renewed within the commonwealth shall provide coverage for treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome including, but not limited to, the use of intravenous immunoglobulin therapy.

SECTION 5. Chapter 176G of the General Laws is hereby amended by inserting after section 4FF the following section:-

Section 4GG. Any individual or group health maintenance contract shall provide coverage for treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome including, but not limited to, the use of intravenous immunoglobulin therapy.

SECTION 6. This act shall apply to contracts that take effect or are renewed on or after January 1, 2022.